Replies to post #20330 on The Rising Influence of Rising Affluence

[OakesCS]

If HAL has the $, they could stick it to SLB by buying CLB and my understanding of CLB’s operational model would fit better w HAL. Baker would b smart to buy CLB but I don’t know if they have the $. SLB would destroy any value from CLB.

I don’t think the service industry will be recovering anytime soon so any purchase would have to b done by someone who doesn’t crimp whatever cash CLB generates.

There r some small analytical service companies, eg Von Gonten, that might b cutting into CLB’s biz. I don’t know if the pack of small companies pose a long term threat to CLB’s position and any buyout vig.

[biotech_researcher]

I was using CLB as my leading indicator for recovery in this space, so I suppose I can pull this and others related off my watch list for a few quarters..

[DewDiligence]

CLB’s CEO is retiring, which is consistent with my musings on buyout vig in #msg-153050277.

From the 4Q19 PR:

David Demshur, after more than 25 years as Core Lab’s Chairman and Chief Executive Officer, a tenure rarely achieved in any industry, is announcing his plans to retire effective 31 December 2020. Mr. Demshur will transition from the roles of Chairman and Chief Executive Officer on 20 May 2020, coinciding with Core Lab’s Annual Shareholders’ Meeting. Mr. Demshur will not seek re-nomination to the Company’s Supervisory Board of Directors in 2020.

I’m not clear on what Demshur’s role will be between 5/21/20 and 12/31/20.